Group One Trading
CLSD

Group One Trading’s Clearside Biomedical CLSD Stock Holding History

Group One Trading’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-908
Closed -$14.9K – 7344
2024
Q3 		$17.3K Buy
+908
New +$15.5K ﹤0.01% 5309
2023
Q4 		– Sell
-106
Closed -$1.51K – 7466
2023
Q3 		$1.38K Hold
106
– – ﹤0.01% 7147
2023
Q2 		$1.78K Hold
106
– – ﹤0.01% 7118
2023
Q1 		$1.65K Buy
+106
New +$2.06K ﹤0.01% 6654
2022
Q4 		– Sell
-177
Closed -$3.19K – 7318
2022
Q3 		$3K Sell
177
-1,333
-88% -$29.2K ﹤0.01% 7003
2022
Q2 		$33K Sell
1,510
-80
-5% -$1.94K ﹤0.01% 5906
2022
Q1 		$55K Sell
1,590
-9,267
-85% -$277K ﹤0.01% 6018
2021
Q4 		$448K Buy
10,857
+8,977
+478% +$581K ﹤0.01% 4256
2021
Q3 		$169K Buy
+1,880
New +$166K ﹤0.01% 5349
2021
Q1 		– Sell
-301
Closed -$15.1K – 7618
2020
Q4 		$12K Buy
+301
New +$7.81K ﹤0.01% 5716
2020
Q3 		– Sell
-37,860
Closed -$978K – 6122
2020
Q2 		$1.07M Buy
37,860
+6,075
+19% +$179K ﹤0.01% 1960
2020
Q1 		$811K Buy
31,785
+21,643
+213% +$800K 0.01% 1689
2019
Q4 		$441K Buy
+10,142
New +$213K ﹤0.01% 2537
2019
Q3 		– Sell
-2,421
Closed -$35K – 5183
2019
Q2 		$35K Hold
2,421
– – ﹤0.01% 3954
2019
Q1 		$50K Buy
2,421
+1,660
+218% +$32.9K ﹤0.01% 3565
2018
Q4 		$12K Sell
761
-260
-25% -$12.2K ﹤0.01% 4196
2018
Q3 		$94K Sell
1,021
-906
-47% -$108K ﹤0.01% 3582
2018
Q2 		$309K Buy
1,927
+1,844
+2,222% +$311K ﹤0.01% 2693
2018
Q1 		$13K Buy
+83
New +$10.1K ﹤0.01% 4229

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's CLSD Position: Q4 2024 in Review

Group One Trading sold out of Clearside Biomedical (CLSD) in Q4 2024, closing a stake of 908 shares — an estimated $14.9K sold.

Group One Trading first reported a position in CLSD in Q1 2018 and held it in 19 quarters. The position peaked at $1.07M in Q2 2020. 43 funds tracked by Wall St. Rank hold CLSD as of Q4 2024.

  • Group One Trading reported no remaining Clearside Biomedical position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 908 Clearside Biomedical shares in Q4 2024, an estimated $14.9K.
  • Group One Trading first reported a position in Clearside Biomedical in Q1 2018 and held it in 19 quarters.
  • Group One Trading's Clearside Biomedical position peaked at $1.07M in Q2 2020.
  • 43 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.